Lowe F C, Dreikorn K, Borkowski A, Braeckman J, Denis L, Ferrari P, Gerber G, Levin R, Perrin P, Senge T
Department of Urology, St. Luke's-Roosevelt Hospital, New York, New York 10019, USA.
Prostate. 1998 Nov 1;37(3):187-93. doi: 10.1002/(sici)1097-0045(19981101)37:3<187::aid-pros8>3.0.co;2-t.
In order to assess the efficacy of phytotherapeutic agents for the treatment of benign prostatic hyperplasia (BPH), a review of recently published double-blind placebo-controlled trials was undertaken.
Only those studies reviewed by the Other Medical Therapies Committee of the Fourth International Consultation on BPH were included.
These studies suggest a possible benefit for the use of phytotherapeutic preparations in the treatment of BPH.
These studies need to be confirmed in larger long-term placebo-controlled studies in order to ascertain the true efficacy of these agents.
为评估植物治疗药物治疗良性前列腺增生(BPH)的疗效,对近期发表的双盲安慰剂对照试验进行了综述。
仅纳入了第四届国际BPH咨询会其他医学疗法委员会所综述的研究。
这些研究表明植物治疗制剂用于治疗BPH可能有益。
这些研究需要在更大规模的长期安慰剂对照研究中得到证实,以确定这些药物的真正疗效。